NuProbe - Crunchbase Company Profile & Funding

Q: Where is NuProbe's headquarters?

NuProbe is located in Boston, Massachusetts, United States.

Q: Who invested in NuProbe?

NuProbe has 16 investors including HSG And Pan-Lin Capital.

Q: When was the last funding round for NuProbe?

NuProbe closed its last funding round on obfuscated from a Series B round.

Overview

NuProbe

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About NuProbe

CB Rank

30205

NuProbe is a cutting-edge genomics and molecular diagnostics company.

Founded

obfuscation

Private

Series B

Boston, Massachusetts, United States

11-50

nuprobe.com/

Biotechnology

Health Care

Health Diagnostics

Funding Rounds

Series B

OBF

obfuscation

Series B

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Junfeng Luo: Co-Founder & Vice President, R&D - NuProbe, China
David Yu Zhang: Co-Founder and General Manager
Past Role: NuProbe, Co-Founder & Head of Innovation

Details

Legal Name

NUPROBE USA, INC.

Operating Status

Active

Company Type

For Profit

Founders

David Yu Zhang, David Zhang, Junfeng Luo, Peng Yin, Victor Chenyang Shi, Yingshuang Chai, Yundi Chen

About the Company

NuProbe is a cutting-edge genomics and molecular diagnostics company.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Blocker Displacement Amplification (BDA)

A PCR-based rare allele enrichment method that selectively amplifies low-frequency DNA variants down to 0.01% variant allele frequency (VAF).

Quantitative Amplicon Sequencing (QASeq)

A targeted amplicon-based NGS method for simultaneous detection and quantification of copy number variations (CNVs) and mutations with high sensitivity.

Research & Development

NuProbe is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - NuProbe	9	obfuscated obfuscation	CICC Healthcare Investment Fund, CR-CP Life Science Fund, Pan-Lin Capital	Series B
obfuscated obfuscation	Series B - NuProbe	9	obfuscated obfuscation	CICC Healthcare Investment Fund, CR-CP Life Science Fund, Pan-Lin Capital	Series B
obfuscated obfuscation	Series B - NuProbe	9	obfuscated obfuscation	CICC Healthcare Investment Fund, CR-CP Life Science Fund, Pan-Lin Capital	Series B
obfuscated obfuscation	Series B - NuProbe	9	obfuscated obfuscation	CICC Healthcare Investment Fund, CR-CP Life Science Fund, Pan-Lin Capital	Series B
obfuscated obfuscation	Series B - NuProbe	9	obfuscated obfuscation	CICC Healthcare Investment Fund, CR-CP Life Science Fund, Pan-Lin Capital	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - NuProbe	9	obfuscated obfuscation	CICC Healthcare Investment Fund, CR-CP Life Science Fund, Pan-Lin Capital	Series B
obfuscated obfuscation	Series B - NuProbe	9	obfuscated obfuscation	CICC Healthcare Investment Fund, CR-CP Life Science Fund, Pan-Lin Capital	Series B
obfuscated obfuscation	Series B - NuProbe	9	obfuscated obfuscation	CICC Healthcare Investment Fund, CR-CP Life Science Fund, Pan-Lin Capital	Series B
obfuscated obfuscation	Series B - NuProbe	9	obfuscated obfuscation	CICC Healthcare Investment Fund, CR-CP Life Science Fund, Pan-Lin Capital	Series B
obfuscated obfuscation	Series B - NuProbe	9	obfuscated obfuscation	CICC Healthcare Investment Fund, CR-CP Life Science Fund, Pan-Lin Capital	Series B